Can Diagnostics Aid in Alleviating Antimicrobial Resistance and Sepsis?
Antimicrobial resistance (AMR) continues to be an increasingly significant public health issue, leading to higher mortality rates. One study estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.1 Untreated or undertreated bacterial infections are a major cause of sepsis—a serious complication that places a […]
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
More than 80% of adults in Sierra Leone said they would accept COVID-19 vaccines for themselves or their families, according to a study presented at the 2025 Annual Conference on Vaccinology Research. The study surveyed 2,146 adults to assess vaccine awareness, acceptance, and hesitancy. Researchers from Emory University, the University of Siena, and other institutions […]
Overcoming Barriers and Embracing Long-Acting PrEP
Zandraetta Tims-Cook, MD, MPH, an infectious diseases physician focused on HIV health disparities in Atlanta, has dedicated her career to HIV prevention and outreach, particularly for women living with HIV. Since 2008, she has worked to bridge gaps in care and improve prevention strategies for high-risk populations. In our interview, Tims-Cook discussed overcoming barriers to […]
Investigational Long COVID Therapy Enrolls First Phase 2 Participant
Carson City, Nevada-based NevBiovie announced today it has enrolled its first participant for it phase 2 clinical trial, ADDRESS-LC, which will study its investigational therapy, bezisterim, and will evaluate its safety and efficacy on motor and non-motor symptoms in patients who have not been treated with carbidopa/levodopa. “This trial will explore whether targeting these mechanisms […]
Peptide-Decorated Liposomes Enhance Drug Delivery Against Candida auris and Candida albicans
Candida auris cells Image credits: Unsplash Candida infections pose a clinical challenge due to the limited availability of antifungal drugs, biofilm formation, and antifungal drug resistance. One promising approach to address these challenges involves the use of fungi-targeted liposomes to enhance drug delivery and solubility while reducing toxicity. In this recent study, researchers developed liposomes […]
An Infection Prevention Method That We Forget?
Handwashing often takes place after encounters with people, using the bathroom, or touching doors or other areas where the public has been utilizing. However, it can be quite a personal decision and one associated with people’s beliefs about germs. A new survey commissioned by the National Foundation for Infectious Diseases (NFID) and released as part […]
Addressing the Infectious Disease Challenges in Immunocompromised Patients
Joshua A Hill, MD, FIDSA, an infectious disease specialist at Fred Hutchinson Cancer Center and the University of Washington Medical Center, is focused on improving care for immunocompromised patients who face risks from infections and are often excluded from clinical research. “Our patient population that we treat here in Seattle at our academic medical centers […]
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
This deer tick, or blacklegged tick, Ixodes scapularis, as it was questing on a blade of grass. The Lyme disease bacterium, Borrelia burgdorferi, is spread through the bite of infected ticks. The blacklegged tick spreads the disease in the northeastern, mid-Atlantic, and northcentral United States, while the western blacklegged tick, Ixodes pacificus, spreads the disease […]
Safety and Immunogenicity Results for GS-2829 and GS-6779
A Phase 1a study in New Zealand evaluated the safety, tolerability, and immunogenicity of two novel arenaviral vectored vaccines, GS-2829 and GS-6779, for hepatitis B virus (HBV) infection. The study enrolled 51 healthy participants, aged 33 on average, who received varying doses of the vaccines via intramuscular administration to assess safety and immune response. The […]
Another Vaccine-Preventable Disease Seeing a Major Resurgence
Pertussis (whooping cough) is a bacterial infection caused by the bacterium Bordetella pertussis, and is spread through respiratory droplets when an infected person coughs or sneezes.1 In the US, there were 35,435 reported cases of pertussis last year—the highest number in more than a decade. For comparison, there were 7,063 cases in 2023.2 Through the […]
